The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis
Benefits offered by microbial biomanufacturing, such as low
production costs and faster development timelines, have led many innovators to
adopt these platforms for next generation biologics, offering lucrative
opportunities for CMOs / CDMOs
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Microbial
Contract Biomanufacturing Market, 2020-2030.
The
report features an extensive study of the current market landscape and future
opportunities associated with the microbial contract biomanufacturing market. It features
a detailed analysis of key drivers and trends related to this evolving domain. In
addition to other elements, the study includes:
§ A
detailed review of the current landscape of companies offering contract
manufacturing services.
§ Elaborate
profiles of key players that specialize in offering services for contract biomanufacturing.
§ A competitiveness
analysis, highlighting key players engaged in microbial based contract
manufacturing, featuring insightful pictorial summaries and representations.
§ An
analysis of the partnerships and expansions that have been established in this
domain, in the recent past.
§ A
competitiveness analysis, highlighting key players engaged in microbial based
contract manufacturing, featuring insightful pictorial summaries and
representations.
§ A
detailed proprietary 2×2 representation to assess the current market scenario
§ An
analysis of the initiatives of big biopharma players engaged in this domain.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Type of Product
§
API
§
FDF
To request for Sample Report – https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market/request-sample.html
§ Type
of Biologic
§ Proteins
§ Enzymes
§ Growth
Hormones
§ Antibody
based Drugs
§ Others
(plasmid DNA, probiotics, microbiome-based biologics)
§
Type of Microbial Expression System
§ Bacteria
§ Yeast
§ Others
(Algae and fungi)
§ Scale
of Operation
§ Commercial
§ Preclinical
/ Clinical
§ Type
of End User
§ Small
Companies
§ Mid-sized
Companies
§ Large
/ Very Large Companies
To request
for Customize Report - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market/request-customization.html
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia
Pacific
§ Middle
East and North Africa
§ Latin
America
Key
companies covered in the report
§ AGC
Biologics
§ Aldevron
§ BioVectra
§ EirGenix
§ Etinpro
§ Eurogentec
§ Northway
Biotechpharma
§ Ology
Bioservices
§ Porton
Biopharma
§ Stelis
Biopharma
For additional
details, please visit
https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or
email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Drug
Repurposing Service Providers Market, 2020 – 2030
2.
Antibody
Discovery Services and Platforms Market (3rd Edition), 2020-2030
3.
Live
Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical
Ingredients and Finished Dosage Forms, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment